Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal

Documenti analoghi

• Compared to Subcutaneous Tenofovir, Oral Tenofovir Disoproxyl Fumarate Administration Preferentially Concentrates the Drug into Gut-Associated Lymphoid Cells in Simian Immunodeficiency Virus-Infected Macaques
  di: Van Rompay, Koen K. A., et al.
  Pubblicazione: (2012)
• Structured Treatment Interruptions with Tenofovir Monotherapy for Simian Immunodeficiency Virus-Infected Newborn Macaques
  di: Van Rompay, Koen K. A., et al.
  Pubblicazione: (2006)
• Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
  di: Van Rompay, Koen KA, et al.
  Pubblicazione: (2007)
• A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with Simian Immunodeficiency Virus SIVmac251
  di: Van Rompay, Koen K. A., et al.
  Pubblicazione: (2014)
• Reversion of the M184V Mutation in Simian Immunodeficiency Virus Reverse Transcriptase Is Selected by Tenofovir, Even in the Presence of Lamivudine
  di: Murry, Jeffrey P., et al.
  Pubblicazione: (2003)